Vote Scores

Home / Companies / Structure Therapeutics Inc. / 17 Jun 2026

Meeting · year to 30 June 2026276 filers reporting

Structure Therapeutics Inc.: meeting of 17 Jun 2026

Votes reported on Form N-PX, item by item

276 Form N-PX filers reported votes at the Structure Therapeutics Inc. meeting of 17 Jun 2026. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

3 nominees; 96.0% of reported votes for; 10 filers withheld from or voted against at least one nominee.

426 vote records from 92 filers. 1 of the 92 filers that marked the item either way voted against management.

98.9% for0.0% against1.1% other1.1% against management92 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

352 vote records from 274 filers. 15 of the 258 filers that marked the item either way voted against management. 16 filers reported this item without a management mark.

88.0% for5.8% against6.2% other5.8% against management274 filers96.1% for3.9% against0.0% other3.9% against management78,772,999 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

142 vote records from 92 filers. 1 of the 92 filers that marked the item either way voted against management.

98.9% for0.0% against1.1% other1.1% against management92 filers99.9% for0.0% against0.1% other0.1% against management20,161,116 reported shares

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalNo reportForNo report
State Street and SPDRForForFor
American CenturyForAgainst *For
Franklin TempletonForForFor
InvescoForAgainst *For
EquitableForForFor
Charles SchwabNo reportForNo report
Nuveen and TIAANo reportForNo report
ProShares and ProFundsForForFor
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertForForFor
Goldman SachsForForFor
WisdomTreeForForFor
PGIM and PrudentialForForFor
Jackson National fundsForForFor
Northern Trust and FlexSharesNo reportForNo report
SEINo reportForNo report
T. Rowe PriceForForFor
Lincoln FinancialForNo reportFor
First TrustForForFor
Russell InvestmentsNo reportForNo report
Victory CapitalForForFor
Brighthouse FundsForForFor
Columbia ThreadneedleForForFor
BNY MellonNo reportForNo report
PrincipalForForFor
AllianceBernsteinForForFor
Hartford FundsForForFor
AllspringForForFor
MassMutualForForFor
Macquarie and Delaware FundsForForFor
Janus HendersonForForFor
Natixis and Loomis SaylesNo reportForNo report
BairdNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Structure Therapeutics Inc. meeting?

276 Form N-PX filers reported votes at the meeting of 17 Jun 2026. On say-on-pay, 15 of 258 voted against management (5.8%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Structure Therapeutics Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Structure Therapeutics Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Structure Therapeutics Inc. with a meeting date within three days of 17 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.